Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,983 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma.
Glavey SV, Manier S, Natoni A, Sacco A, Moschetta M, Reagan MR, Murillo LS, Sahin I, Wu P, Mishima Y, Zhang Y, Zhang W, Zhang Y, Morgan G, Joshi L, Roccaro AM, Ghobrial IM, O'Dwyer ME. Glavey SV, et al. Among authors: wu p. Blood. 2014 Sep 11;124(11):1765-76. doi: 10.1182/blood-2014-03-560862. Epub 2014 Jul 24. Blood. 2014. PMID: 25061176 Free PMC article. Clinical Trial.
Targeting bone in myeloma.
Morgan GJ, Wu P. Morgan GJ, et al. Among authors: wu p. Recent Results Cancer Res. 2012;192:127-43. doi: 10.1007/978-3-642-21892-7_6. Recent Results Cancer Res. 2012. PMID: 22307373 Review.
Targeting bone as a therapy for myeloma.
Wu P, Morgan GJ. Wu P, et al. Cancer Microenviron. 2011 Dec;4(3):299-311. doi: 10.1007/s12307-011-0079-2. Epub 2011 Aug 11. Cancer Microenviron. 2011. PMID: 21833747 Free PMC article.
The impact of response on bone-directed therapy in patients with multiple myeloma.
Larocca A, Child JA, Cook G, Jackson GH, Russell N, Szubert A, Gregory WM, Brioli A, Owen RG, Drayson MT, Wu P, Palumbo A, Boccadoro M, Davies FE, Morgan GJ. Larocca A, et al. Among authors: wu p. Blood. 2013 Oct 24;122(17):2974-7. doi: 10.1182/blood-2013-04-498139. Epub 2013 Aug 23. Blood. 2013. PMID: 23974194 Free article. Clinical Trial.
MMSET is the key molecular target in t(4;14) myeloma.
Mirabella F, Wu P, Wardell CP, Kaiser MF, Walker BA, Johnson DC, Morgan GJ. Mirabella F, et al. Among authors: wu p. Blood Cancer J. 2013 May 3;3(5):e114. doi: 10.1038/bcj.2013.9. Blood Cancer J. 2013. PMID: 23645128 Free PMC article. No abstract available.
Response and biological subtype of myeloma are independent prognostic factors and combine to define outcome after high-dose therapy.
Brioli A, Boyd KD, Kaiser MF, Pawlyn C, Wu P, Gregory WM, Owen R, Ross FM, Jackson GH, Cavo M, Davies FE, Morgan GJ. Brioli A, et al. Among authors: wu p. Br J Haematol. 2013 Apr;161(2):291-4. doi: 10.1111/bjh.12218. Epub 2013 Jan 29. Br J Haematol. 2013. PMID: 23356460 Free article. Clinical Trial. No abstract available.
13,983 results
You have reached the last available page of results. Please see the User Guide for more information.